SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending due to recent analyst upgrades and positive clinical trial data from its oncology pipeline, including for breast and lung cancer, signaling its strategic pivot towards cancer therapeutics. However, community discussions remain highly polarized, with significant chatter debating the safety and efficacy of mRNA vaccines and broader regulatory scrutiny.

Teucrium Trading, LLC - Teucrium Wheat Fund

Teucrium Wheat Fund

WEAT is seeing significant discussion as global geopolitical tensions in regions like the Middle East and Russia/Ukraine, alongside emerging weather disruptions impacting key agricultural areas, fuel speculation around wheat supply. The community is sharply divided, with bulls anticipating a short-covering rally given record fund short positions, while others point to robust global production and recent trade cancellations.

Direxion Shares ETF Trust - Direxion Daily TSLA Bear 1X ETF

Direxion Daily TSLA Bear 1X Shares

Direxion Daily TSLA Bear 1X Shares ($TSLS) is trending amidst preparations for an upcoming reverse split and strong community sentiment predicting further downside for Tesla. Many traders are actively positioning in TSLS, citing concerns over Tesla's valuation, increasing competition, and recent doubts regarding its strategic initiatives like robotaxis and AI development.

What Is Pi Network? Pi Network is a social cryptocurrency, developer platform, and ecosystem designed for widespread accessibility and real-world utility. It enables users to mine and transact Pi using a mobile-friendly interface while supporting applications built within its blockchain ecosystem.  Supply Model and Mining Mechanism The Maximum Supply of Pi is 100 billion tokens. The Maximum Supply is comprised of the following: 65 Billion tokens (or 65%) are allocated for all community mining rewards; 10 billion (10%) are allocated for foundation reserves; 5 billion (5%) are allocated for liquidity purposes; and 20 billion (20%) are allocated for the Core Team. Each allocation mentioned above tracks the community Migrated Mining Rewards issuance pace, so the proportions of each allocation in the total supply remains the same at any given time.   The Effective Total Supply of Pi—the total Pi supply at the current time—allocates Pi proportionally the same as the Maximum Supply. Since every allocation tracks the Migrated Mining Rewards of the community, the Effective Total Supply can be calculated by dividing the current Migrated Mining Rewards of Pi on the Mainnet blockchain by 65%. The other allocations within the Effective Total Supply can then be calculated based on the same proportions as the Maximum Supply, e.g. at most 10% of the Effective Total Supply is available in the foundation reserve, 5% of the Effective Total Supply is available for liquidity purposes, and 20% of the Effective Total Supply is available for the Core Team. This remains true despite the fact that all tokens were minted at the genesis as technically required by the blockchain protocol.  Circulating Supply includes all Migrated Mining Rewards and all tokens that entered circulation from other buckets of the allocations, which at its maximum could be summed up to equal the Effective Total Supply.   Pi’s mining rewards are distributed based on an issuance formula that follows a declining exponential model defined in the Pi whitepaper. Users can increase the amount of mining rewards they receive based on their individual contributions to the network, like Security Circles, using utility-based Pi apps, running Nodes, etc. For each month, the amount of Pi to be distributed as mobile balance is capped and determined by the model, regardless of how many people or how many types of mining rewards there are during the month. The capping is achieved by the design of a system-wide base mining rate, and each type of mining rewards to each individual are just a multiplier of this base mining rate. As the monthly supplies always diminish, the base mining rate generally decreases over time.   Fewer Pi may also be issued because the real Pi issuance on the blockchain depends on Pioneers passing KYC and completing all steps required for migration to the Mainnet. Despite all efforts to facilitate and remind Pioneers to complete those required steps, there are always dropoffs along the way, resulting in less than all outstanding mobile balances to be issued on the blockchain. Because of this mechanism, the community issued amount (Migrated Mining Rewards) on the blockchain will likely be closer and closer to a line lower than the 65 billion. This is thus the reason for the variable Effective Total Supply which incorporates this effect. Effective Total Supply results from all Migrated Mining Rewards divided by 65%, as opposed to the Maximum Supply of 100 billion.  Ecosystem and Adoption Pi Network has built an integrated ecosystem that facilitates real-world transactions and decentralized applications. Pi can be used as a medium of exchange for goods and services, including online commerce and local brick-and-mortar businesses.  Users can engage with Core Team and community-built apps in the Pi ecosystem through the Pi Browser, where integrated features like the Pi Wallet provide a seamless experience. Events like PiFest 2024 showcased Pi’s growing adoption, with over 27,000 active sellers and 28,000 test merchants across 160 countries.  Who Are the Founders of Pi Network? Pi Network was founded by Dr. Nicolas Kokkalis and Dr. Chengdiao Fan, both of whom have PhDs from Stanford University and a passion for improving human lives through technology.  Dr. Nicolas Kokkalis is a Stanford PhD in EE and postdoc in CS with research on distributed systems and human-computer interaction. His work focuses on combining distributed systems and human computer interaction to bring cryptocurrency to everyday people. As a strong and long-term believer of the technical, financial and social potential of cryptocurrencies, he is determined to move them beyond their current limitations and is committed to bringing the power of blockchain to more people.  Dr. Chengdiao Fan holds a Stanford PhD in Anthropological Sciences, harnessing social computing to unlock human potential on a global scale. Chengdiao is building Pi Network to mobilize individuals all over the world to participate and be rewarded for their contributions, and establish an inclusive ecosystem for global citizens to unleash and capture their own agency, and in turn create utilities and productions for society and the world.  Compliance and Identity Verification Pi Network follows a one-account-per-person policy through its Know Your Customer (KYC) solution. This system combines machine automation and human verification to authenticate user identities while preserving privacy.  The KYC process emphasizes real individuals, combats fraudulent activities and enables fair participation in the mining process of the network. Pi’s identity verification approach balances scalability, security, and accessibility, allowing millions of users worldwide to validate their accounts while maintaining regulatory compliance.

Pi Network

Pi Network is trending following its recent ecosystem development, notably app studio upgrades and a new Web3 gaming integration partnership, though community discussion remains sharply divided between enthusiasm for its future and persistent concerns about token migration and major exchange listings.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as recent FDA approvals for oncology treatments and advancements in its obesity drug portfolio are weighed against analyst downgrades and concerns over future growth, driving mixed community discussion around its dividend appeal and perceived stock underperformance.

BlockDAG

BlockDAG ($BDAG) is trending as its community grapples with significant challenges claiming presale tokens and navigating wallet compatibility issues, leading to widespread accusations of a potential scam. While some investors remain optimistic about its long-term potential, the immediate conversation is dominated by concerns over token distribution and the uncertainty surrounding its launch and exchange listings.

SM Energy Co. is an independent energy company, which engages in the provision of acquisition, exploration, development, and production of oil, gas, and natural gas liquids. The company was founded in 1908 and is headquartered in Denver, CO.

SM Energy Co

Escalating geopolitical tensions impacting global oil supply, alongside SM Energy's transformative merger with Civitas and strategic Uinta Basin acquisition, are driving bullish sentiment as the community views the stock as significantly undervalued. The company's focus on debt reduction, increased dividends, and share repurchases further reinforces confidence in its future value.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

Gasspas ($GASS) is experiencing a surge in speculative interest, with its community actively debating its potential for significant gains and "dropping zeros" akin to other successful memecoins. However, this enthusiasm is sharply contrasted by widespread concerns regarding an reportedly abandoned development team and persistent reports of failed transactions on platforms like Uniswap, leading many to label it a "pump and dump."

Realty Income Corp. is a real estate company, which engages in generating dependable monthly cash dividends from a consistent and predictable level of cash flow from operations. The company was founded by William E. Clark, Jr. and Evelyn Joan Clark in 1969 and is headquartered in San Diego, CA.

Realty Income Corp.

Anticipation of imminent interest rate cuts is driving significant discussion around Realty Income, a key catalyst for REITs, while its consistent monthly dividend and recent stock performance attract income-focused investors. The community is actively weighing its diversified portfolio and strategic global expansions against valuation concerns and the impact of macro pressures on its long-term growth prospects.

Vanguard Star Funds - Vanguard Total International Stock ETF

Vanguard Total International Stock ETF

Vanguard Total International Stock ETF ($VXUS) is trending as international markets are currently outperforming US equities, attracting substantial inflows as investors seek diversification. Community discussion highlights a "Sell America" narrative, driven by a weakening dollar and shifting confidence in global economic leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Incannex Healthcare (NASDAQ:IXHL) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Incannex Healthcare to a "sell" rating in a report on Saturday...

Incannex Healthcare (NASDAQ:IXHL) Stock Price Down 11% - What's Next?

Incannex Healthcare (NASDAQ:IXHL) Stock Price Down 11% - Here's Why...

<ul class="summary-bullets"><li>The reverse split will consolidate every 30 existing shares into one new share.</li><li>The move is intended to help the company comply with Nasdaq’s minimum bid price requirements.</li><li>After the split, the company’s outstanding shares will decrease from roughly 358.3 million to about 11.94 million.</li></ul>Incannex Healthcare Inc. (IXHL) announced on Wednesday that its board of directors has approved a 1-for-30 reverse stock split, which was previously approved by shareholders at a special meeting on May 27, 2025.The reverse split is set to take legal effect at 4:01 p.m. ET on Feb. 26, 2026.<h2 class="st-heading-2">Purpose And Impact Of The Split</h2>Following this adjustment, Incannex Healthcare common shares will begin trading on The Nasdaq Capital Market under a new CUSIP number, 45333F 208, on February 27, while retaining the ticker symbol ‘IXHL’.The reverse split will consolidate every 30 existing shares into one new share, aiming to raise the per-share market price. The move is intended to help the company comply with Nasdaq’s minimum bid price requirements and maintain continued listing eligibility.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/IXHL">Incannex stock</a> tumbled over 32% on Wednesday morning. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Share Structure And Equity Adjustments</h2>Incannex said that&nbsp;no fractional shares will be issued, and shareholders entitled to fractional amounts will receive an additional share to round up to a whole unit.&nbsp;After the split, the company’s outstanding shares will decrease from roughly 358.3 million to about 11.94 million, although the total number of authorized shares will remain unchanged. Existing equity awards and stock incentive plans will see proportional adjustments in both share numbers and exercise prices to reflect the split.&nbsp;In January, Incannex said it is entering 2026 with over $70 million in cash, following a $12.5 million private placement financing and the elimination of legacy Series A warrants. The company also authorized a $20 million share repurchase program.IXHL stock has declined by over 87% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-q4-earnings-today-retail-says-pressure-is-worse-this-time/cZRy3JBRIG4">Nvidia Q4 Earnings Today – Retail Says 'Pressure Is Worse This Time’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Incannex Healthcare Inc. logo is seen on a smartphone and in the background.

Why Did IXHL Stock Tank Over 32% Today? 

The company’s board approved a 1-for-30 reverse stock split, effective on February 26. The move is intended to help the company comply with Nasdaq’s minimum bid price requirements.

Equity

The company’s board approved a 1-for-30 reverse stock split, effective on February 26. 


Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest

Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant increase in short interest in January. As of January 30th, there was short interest totaling 21,688,567...

Incannex Healthcare (NASDAQ:IXHL) Announces Quarterly Earnings Results

Incannex Healthcare (NASDAQ:IXHL - Get Free Report) issued its earnings results on Friday. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02...

Incannex Healthcare (IXHL) Expected to Announce Quarterly Earnings on Friday

Incannex Healthcare (NASDAQ:IXHL) will be releasing its Q2 2026 earnings before the market opens on Friday, February 13. (View Earnings Report at...

Short Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Decreases By 30.9%

Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 15,236,764 shares...

Incannex Healthcare (NASDAQ:IXHL) Trading Up 2.1% - Still a Buy?

Incannex Healthcare (NASDAQ:IXHL) Stock Price Up 2.1% - Time to Buy...

Incannex Healthcare (NASDAQ:IXHL) Trading Down 8.8% - Here's What Happened

Incannex Healthcare (NASDAQ:IXHL) Trading Down 8.8% - Should You Sell...

Penny Stocks To Keep An Eye On - December 3rd

iRobot, Richtech Robotics, Bitfarms, Virax Biolabs Group, Nauticus Robotics, Incannex Healthcare, and Fusion Fuel Green are the seven Penny stocks to watch today, according to MarketBeat's stock...

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Up 5%+

Up 0–5%

Down 0–5%

Down 5%+

Stocktwits

Stocktwits Polls

Incannex Healthcare Limited - ADR

Traders are hilariously fixated on the CEO's forehead, making it a bizarrely popular running gag and a symbol for big ideas or impending news.

Anticipation is high for the FDA's End-of-Phase-2 meeting feedback, a critical regulatory step that could clarify Phase 3 strategy or signal a major partnership.

The stock is nearing its 10-day mark above $1 for Nasdaq compliance, with many debating if this milestone will spark new investment or precede further dilution.

Many believe the company is significantly undervalued, trading below cash per share and expecting a massive re-rating or buyout due to its drug pipeline potential.

Frustration is mounting over perceived poor management decisions, including recent reverse splits, dilution concerns, and a lack of transparent communication with shareholders.

Current Price	$3.90
Prev Close	$4.00
Open	$3.90
Dividend Yield	0.00%
50-Day Moving Average	$9.07
Beta	-0.23
Avg. Volume	335,629.38
PE Ratio	-0.17

52-Week High	$49.80
52-Week Low	$2.40
Market Capitalization	$46.58M
EPS (Annual)	-$40.82
Price to Book	0.64
Revenue Per Employee	$7,166.67

IXHL
Incannex Healthcare Limited - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest IXHL News

IXHLIncannex Healthcare Limited - ADR